Forte Biosciences
FBRX
FBRX was delisted on the 26th of August, 2026.
27 hedge funds and large institutions have $42.1M invested in Forte Biosciences in 2020 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 13 reducing their positions, and 30 closing their positions.
1,451% more capital inflows, than outflows
Capital inflows: $48.6M | Capital outflows: $3.13M
5.28% more ownership
Funds ownership: 21.43% → 26.71% (+5.3%)
46% less funds holding
Funds holding: 50 → 27 (-23)
69% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 13
77% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 30
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BVF Inc
San Francisco,
California
|
+$17.5M |
| 2 |
OrbiMed
New York
|
+$17M |
| 3 |
Fred Alger Management
New York
|
+$12.9M |
| 4 |
MA
MYDA Advisors
Woodmere,
New York
|
+$515K |
| 5 |
Jane Street
New York
|
+$182K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$1.11M |
| 2 |
State Street
Boston,
Massachusetts
|
-$430K |
| 3 |
Morgan Stanley
New York
|
-$356K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$248K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$117K |
FBRX Hedge Fund Activity: Q2 2020 in Review
27 of the 4,890 institutional investors tracked by Wall St. Rank reported a position in Forte Biosciences (FBRX) for Q2 2020, worth a combined $42.1M — up 573% from $6.25M a quarter earlier.
Sellers outnumbered buyers: 30 funds closed out of FBRX and 7 opened new positions — a net loss of 23 holders — while 13 trimmed existing stakes and 4 added.
The largest buyer was BVF Inc, opening a new position worth an estimated $17.5M. The largest seller was BlackRock, cutting an estimated $1.11M.
- 27 institutional investors held Forte Biosciences (FBRX) as of Q2 2020, down from 50 in Q1 2020.
- Funds reported $42.1M of Forte Biosciences stock for Q2 2020, up 573% quarter-over-quarter.
- 7 funds opened new Forte Biosciences positions in Q2 2020 and 30 closed out, a net change of -23 holders.
- The largest Forte Biosciences buyer in Q2 2020 was BVF Inc, an estimated $17.5M added.
- The largest Forte Biosciences seller in Q2 2020 was BlackRock, an estimated $1.11M sold.
Based on aggregated 13F filings for Q2 2020.